2024 Annual Meeting | C204 - Autoimmune Neurology: Central Nervous System

Date Thursday 04/18/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Location Colorado Convention Center | Mile High 2/3

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Alfonso S. Lopez, MD

Topic(s) Autoimmune Neurology

Learning Objectives Participants should become familiar with the differential diagnosis and management of CNS immune mediated disorders.

CME Available 2.00 CME credits

Core Competencies Medical Knowledge, Systems-based Practice

Program Level Intermediate

Program Tracks Neurohospitalist

Recommended Audience General Neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
01:00 PM - 01:35 PM MDT	Speaker	From Neural Autoantibody Discovery to Clinical Testing Anastasia Zekeridou, MD, PhD, FAAN
01:35 PM - 02:10 PM MDT	Speaker	Neurological Manifestations in Autoinflammatory Diseases Ariane Soldatos, MD, FAAN
02:10 PM - 02:45 PM MDT	Speaker	Autoimmune Encephalitis Misdiagnosis Alfonso S. Lopez, MD
02:45 PM - 03:00 PM MDT	Q&A	Questions and Answers Alfonso S. Lopez, MD, Ariane Soldatos, MD, FAAN, Anastasia Zekeridou, MD, PhD, FAAN

Faculty Disclosures
Alfonso S. Lopez, MD	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech .
Ariane Soldatos, MD, FAAN	Dr. Soldatos has nothing to disclose.
Anastasia Zekeridou, MD, PhD, FAAN	The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.